Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

MPLX LP
Next earnings Aug 4, 2026 · consensus $1.12 EPS, $3.23B rev
Last earnings -2.6% on 2026-05-05
Steady fee-based midstream compounding earnings double-digits at ~11.7x P/E with ~$4B free cash flow — cheap quality, own it.
Sources: SEC EDGAR (CIK 0001552000, latest 10-Q filed 2026-05-05) · EODHD · analysis by claude-code · as of 6/21/2026, 3:57:32 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
MPLX is exactly what a midstream MLP should look like: five straight years of higher revenue ($8.02B→$9.73B since FY2021) and net income ($3.11B→$4.95B), with FY2025 net income up 13.7% and operating income up 12.4% — earnings growing roughly twice as fast as the 5.8% top line, a sign of fee-based operating leverage. Margins are extraordinary and stable for the model (61.1% operating, 50.9% net), and the business throws off cash: $5.91B operating cash flow against $1.81B capex leaves ~$4.1B of free cash, comfortably funding the $400M of buybacks (+22.7%) while cash on hand grew 40.7% to $2.14B. On valuation this is the crux — at a $57.7B cap on $4.95B of net income the stock trades near 11.7x earnings (P/S 5.9), an undemanding multiple for an asset with this consistency and cash generation.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $8.02B | $8.92B | $8.73B | $9.19B | $9.73B |
| Gross profit | — | — | — | — | — |
| Operating income | $3.99B | $4.91B | $4.90B | $5.29B | $5.94B |
| Net income | $3.11B | $3.98B | $3.97B | $4.36B | $4.95B |
| Diluted EPS | — | — | — | — | — |
| Net margin | 38.8% | 44.6% | 45.4% | 47.4% | 50.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1 2026 10-Q; balance sheet expanding, capex stepped up materially YoY
Q1 2026 10-Q; balance sheet expanding, capex stepped up materially YoY
New material agreement, a termination, fresh debt obligation, plus earnings exhibit
Officer/director change (Item 5.02); no financial impact disclosed
FY2025 10-K: 61% op margin, 53% ROE; liabilities/equity rose to 3.08x on +21% debt
Other event disclosure (Item 8.01) with exhibits; routine, no clear P&L impact
FY2025 results: revenue $9.73B (+5.8%), net income $4.95B (+13.7%)
Leadership/board change (Item 5.02); no financial details disclosed
Q3 2025 10-Q; routine quarterly update, growth trajectory intact
1482 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-05-15 | Walker Ray N JR Director | Award | 78.44 | |
| 2026-05-15 | SURMA JOHN P Director | Award | 1.66K | |
| 2026-05-15 | STICE J MICHAEL Director | Award | 1.10K | |
| 2026-05-15 | SEMPLE FRANK M Director | Award | 1.19K | |
| 2026-05-15 | Peiffer Garry L. Director | Award | 1.30K | |
| 2026-05-15 | HELMS CHRISTOPHER A Director | Award | 1.42K | |
| 2026-05-15 | Breves Christine S Director | Award | 276.83 | |
| 2026-04-30 | Walker Ray N JR Director | Award | 2.25K |